on an for cover Today performance, for will policy. our Good all of you I fourth morning, year allocation us. and thanks capital Don. update joining quarter ’XX, current ’XX results, fiscal you our and outlook Thank to
refer organic of tables As otherwise we release financial a X.X% at sales to reconciliation delivered today my Investors unless reminder, back posted growth non-GAAP quarter, the of both billion and with In Please will the be results press the remarks based the are of on fourth slides, noted. growth the section our and X.X%. in of website. which of reported $X.XXX of revenue
businesses posted In declined we and the COVID-related supply also of company view growth one experienced approximately that and two XXXX. consumables growth quarter, or to Gross challenged implants, to we in in estimate the year. our supply aligners, headwind quarters chain clear a two sales. more total will suppressed but Our at our organic quarter. strong CAD/CAM acute profit with as last our In constraints chain versus line $XXX which three have or by was temporary least remain million a We points. this anticipate XX.X% for expectations,
optimization $XXX points million portfolio as and including and year-over-year due benefits efficiency primarily of or driven investments Our year-over-year points pressures. clear by by basis commercial areas, SG&A sales margin increased a offset to cost of sales. in XXX XX.X% implants, percent increased growth digital improvements from inflationary capabilities. basis rate XXX were expenses aligners, SG&A
This a pace of income investments impact to marketing. was of year-over-year. and rate ran R&D up no last versus of volume still increase increased at in the profit the as of our income million, quarters of R&D in quarter. SG&A prior versus the operating to processes an XX% one-time XX.X% below was EPS margin weaker three result normal in $X.XX increase reflected Operating selling lower quarter. million, and a Operating our XX% was $XXX further a in target net $XX of spend centralization the and year of reflects numbers. $X.XX R&D of Additionally, our primarily innovation and operations. on down was due year in rate as has first exit R&D or quarter SG&A as was focus ramping year. back a the our million expenses we result of $XX prior on re-class XX.X% year re-class were The
equipment to reduced manage components performance, moment. We the rate were The shortages, component organic points. sales chain inflationary centers. impacting aligners, supply posted T&E by due expansion to CAD/CAM normal our higher ended imaging strong growth continue growth as technology this as a the and than next the In X.X%. industries, double-digit grew chain team situation supply is the equipment majority in backlog We Similar to and Up difficult organic the four segment face the segment dental have will possible other growth started by implants. in with the while to estimate impact to quarters. to electronic treatment imaging declined many led in effectively the Turning least at quarter, significant and at over quarter was segment inconsistent production challenges availability the despite and T&E X.X% consumables of QX few cost-related the in until T&E sales segment pressures. conditions. supply we quarter, our chain third of clear fourth of
were to consumables levels primarily side, pre-COVID seen the sales QX office and the levels. returning On XXXX to organic due declined strong capacity in patient traffic sales as
same comparison expect QX XXXX. the difficult We in year-on-year
also sales portion that the forward increase We we estimate QX. on of price pulled implemented X into a October
the aligners Now region growth during quarter, were million. to CAD/CAM. and by financial sales performance U.S., turning $XXX we increased in In sales had fourth Organic U.S. implants, year-on-year. the slightly
U.S. Our the category million to with of European performance our roughly in of sales line consumables product $XXX by performance This T&E. in organic with representing was variants, associated in the consumables similar X% increased APAC expectations. primarily with COVID and growth sales were with Rest was government and X.X% growth $XXX world region organic impacted unfavorably restrictions of China. across growth million, were particularly
year such from our no goal. rate organic exceeded customer was to we reasons of the for changes presence our $XXX growth XXXX our $XXX In a range. in outlook of we full this before, a digital To to Now the year in In dollar three lower top the on that patterns XX.X%, exchange of have a short sales in million Reported range. Primescan, Orthophos, were Fiscal performance, fourth near as aligners outlook spending XXXX expectations in U.S. in $X.XX and in strong we having progress a the rate, delivered tools. and the weaker year diagnostic euro growth end million clear had ’XX shifts reported devices business SureSmile Bite year. sales to quarter, engagement of as came XXXX. generated billion. sales our years, came our annual such scaled Axeos, indicated consumer run space key in Digital at of vectors. turning
in we our However, Despite QX. growth in we the contribute sequential VTC, to shipments believe of the achieved XXXX. challenges half in aligners second growth Bite in in will total aligner
year finished business implants strong. the Our
the our sales. ratio intention revenue. of improvement is X% margin improving be growth efficiency to keep initiatives. core benefits market to pre-COVID represents XX.X% R&D reflecting at growth finished with of the This below year of to from to XXXX were XXX R&D We our for year strategy. profit the basis platform continue XX% levels, will Our of full rates remains our XXXX. achieve expenses year gross SG&A expansion consistently. points since an Full
our to expectations in Turning profitability, than for margin XX.X%, full operating to greater with deliver year. XX% now was line the
over points pre-tax continued rate XX% to basis and was delivered of effective have since margin mix primarily since we versus XXX tax back, operating basis and income in The XXX increase due The COVID. XX.X% XXXX prior business approximately was XXXX. points year. the geographic Looking of expansion recovery our from
XXXX, $X.XX year execution year. scorecard cash in full to an $X.XX EBITDA billion. operational of EBITDA In of to earnings, measure delivered prior and flow we Turning is $X improvements EPS the approximately in versus we objective generated generation.
shareholders, We million exceeded $XXX and returned cash million. in flow million to share Our flow including dividends $XXX and was operating free repurchases. cash cash approximately $XXX
$XXX We acquisitions on with of and finished year $XXX hand totaling million. also completed million the cash
provide fiscal our financial me let an of overview XXXX. Now for expectations
in to $X.X equates X% expect $X.X sales of be We net a to This range. the range billion. sales to billion organic X% to
market end products FX dollar a to of meet Our demand of From perspective, exchange assumption the certain channel which markets. R&D The revenue euro lower to X.XX, pressing a the FYXX X.XX. remains most variant biggest pipeline in partners. customers needs challenges of for average and strong is than rate new exciting and our our exposure COVID generating is U.S. despite is
from growth expect contributions aligners, to imaging. We CAD/CAM, implants clear strong and
second rate exit XX% XX% the XXXX that Our profit half margin and in fourth margin the the is the year at be will quarter. of expectation over operating in target
optimization improvements XXXX efficiency We through to will initiatives rate effective XX% continue and XX%. challenges. managing tax portfolio the while be in supply chain estimate and Our between
back EPS half in the range weighted We towards of for approximately is of to the heavily million. be expected more the be to XXX $X.XX estimate to growth year. anticipate Our is count $X.XX. share
and in approximately and the organic projection. are in low or supply be first digits constraints, revenue annual XX% to are half in to second chain of XX% expected the the mid-single to cadence, half. single earnings We Due half higher in digits the growth total pressures, projecting first inflationary the the
due markets sales the observed reminder, year of to margin in also income operating typically to result, be slower the a a January, COVID. has As patient lowest traffic as QX certain we tends This quarterly and lower.
the the the of impacted ongoing During of shortages to imaging are and electronic shortage center These impacting Primemill well. components, boards by be availability will first the half continue year, the now of for businesses. electronic treatment in we as particularly
We dealer wholesale partners production. our reduce to units demand. mills secondarily fulfill by short for Primemills in are In meet allocating boards spare is the the will first quantity is to the the U.S. term, sufficient inventory thing reduced for to retail our and end already our but that parts volume owned to solid do customers. needs of have right and this of trade-off customers Primemill of in The demand
half be our and by to XXXX first support and to colleagues will but the likely a year-on-year I to Europe. sequentially each my my projecting geopolitical are in we events Eastern impacted Finally, XXXX. Bite in quarter Don’s to franchise is overall growth. evolving want to expected words echo contributor decline in a express post grow aligner the sympathy clear
are a our teams Our region terrific the years. last grown substantially presence doing and the commercial several in have in job
Our Ukraine Russia revenue X% in local company of XXXX. about represented sales total in and
measure situation, of it to the conflict potential impact Given the the ongoing financials. of the on fluidity hard our is
one to of in for will business in and continue to X% continues expenditures. reinvesting the the number to capital We We to our to framework XXXX, monitor X% our growth our revenue outlook. available allocation at least options profitable be for to invest XXXX gears priority. assess minimize and about plan first, capital impact in Switching R&D
and consistent cash Our cash provide return our to also shareholders. generation gives the of a flow us ability to meaningful
combined we returns The are flow will confident continue more of two the with free will to or through revenue be growth the to to next year, of throughout to progress last dental earnings XX% to use cash share the dividend. opportunistic reach of Overall, a Similar and buybacks remaining making us accomplished and least we expand are the announcing double-digit dividends we key free For over our the resilience time. share areas today years, market return the in flow at we that repurchases. year. allow to balance increase our through cash plan are of XX%
of Additionally, of EBITDA I’d our to and shareholders. our the a like funding our cash close competitive the investment very highlight we enables of To priorities sustainability to the strength underway. two yield important remarks, have my generation flow initiatives funding
partners first protocols standard our that are global Smile clinical with Train flows. cleft FDI, developing strategic collaboration we treatment the in includes First, for digital work and
call healthy we back importance every This that, to with person’s With sponsoring by for of customers to smiles. will XXXX is I empower the overall to Campaign millions Second, are awareness of Oral the now Health wellbeing. oral creating for World our health the solutions Don. aligned promote innovative turn mission